SynthesisSystematic reviews2025
Coping with copper: a bibliometric analysis of copper's role in cancer pathogenesis and treatment.
Synthesis in Systematic reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Therapeutic horizons of cuproptosis: bibliometric mapping of copper-dependent cell death research and its pharmacological implications.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This bibliometric analysis on copper's role in cancer pathogenesis and treatment, spanning from 2014 to 2024, provides a comprehensive overview of current trends and emerging research areas. It highlights China's dominance in research output and identifies a seminal 2022 study by Tsvetkov Peter as the most cited, cementing its importance in the field. Central keywords such as "DNA damage," "trace elements," and "oxidative stress" reflect the critical roles copper plays in cancer biology. As the field continues to evolve, key areas of focus for future studies are expected to include copper homeostasis, the roles of cuproptosis and ferroptosis, and the development of cancer prognosis models based on cuproptosis. This analysis offers valuable insights for advancing both scientific inquiry and clinical applications in this area.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.